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As the saying goes ‘‘What’s good for the liver is bad for the heart.’’
What is bad for the liver, however, is not necessarily good for the
heart especially when it comes to the inhalation of ambient par-
ticulate matter (PM). In 1993, the Six Cities study [1] provided
evidence that airborne PM increases overall mortality, and fol-
low-up studies [2,3] demonstrate it speciﬁcally increases cardio-
vascular mortality. Twenty years after this landmark study,
Zheng et al. demonstrate that PM exposure is also detrimental
to the liver wherein short-term exposure (10 weeks) of mice on
a low-fat diet to concentrated ambient PM2.5 (CAP) leads to pro-
gressive changes that mirror non-alcoholic steatohepatitis
(NASH). Not only does this study describe CAP-induced changes
in the liver that implicate hepatic inﬂammation and NASH in a
transition to systemic insulin resistance and diabetes, but in
doing so, broadens the ﬁeld of Environmental Cardiology. A
recent epidemiological study positively associates the prevalence
of diabetes (but not of obesity) with an increase in the southeast-
ern U.S. of PM2.5 levels [4], indicating that the mechanism by
which PM2.5 promotes diabetes may not necessarily contribute
to obesity [5]. The current study of Zheng et al. provides evidence
to support this idea. There are, however, several caveats regard-
ing application of rodent studies data for the study of human con-
ditions. For example, the majority of studies using the glucose
tolerance test (GTT) to evaluate systemic insulin resistance in
rodents do so by dosing animals based solely on body weight
(1 mg/g body weight), and not lean mass (mostly skeletal mus-
cle). Because an increase in adipose mass does not necessarily
contribute to an increase in glucose uptake when using the GTT
[6], the likelihood of observing glucose intolerance in obese mod-Journal of Hepatology 20
Keywords: Air pollution; Hepatic inﬂammation; Particulate matter; Pulmonary
clearance.
Received 2 October 2012; received in revised form 4 October 2012; accepted 8 October
2012
qDOI of original article: http://dx.doi.org/10.1016/j.jhep.2012.08.009.
⇑ Tel.: +1 502 852 5836; fax: +1 502 852 3663.
E-mail address: dj.conklin@louisville.edu.
Abbreviations: CAP, concentrated ambient particulate matter; GTT, glucose tole-
rance test; HOMA-IR, homeostasis model assessment of insulin resistance; NASH,
non-alcoholic steatohepatitis; PM2.5, particulate matter 62.5 lm aerodynamic
diameter; PTT, pyruvate tolerance test; TEM, transmission electron microscopy.els increases signiﬁcantly when dosing on body weight alone. In
the current study, however, exposure to CAP did not increase
body weight although lean and fat mass were not speciﬁcally
measured. Nonetheless, when compared with air-exposed con-
trols, CAP-exposed mice had pronounced glucose intolerance
and increased HOMA-IR score. Yet it is interesting to note that
this 10-week CAP exposure (5 days/week) induced both systemic
inﬂammation and insulin resistance independent of obesity,
whereas in a previous report, a 10-week CAP exposure induced
increases in both visceral and subcutaneous fat [7]. Thus, it is
not clear if induction of obesity (or just an increase in a selective
fat depot) is required for hepatic NASH and/or systemic insulin
resistance.Is the liver at the ‘‘heart’’ of PM2.5-induced insulin resistance?
As a result of these ﬁndings, the authors then attempt to connect
CAP-induced changes in the liver with the glucose intolerant
state described above. Yet, the evidence presented is limited
and does not adequately connect the onset of hepatic inﬂamma-
tion with systemic insulin resistance. For example, both systemic
glucose intolerance and NASH-like conditions (i.e., decreased
glycogen levels and increased cholesterol, triglycerides, ﬁbrosis,
F4/80+ cells and inﬂammatory signaling) occur after 10-weeks
of CAP exposure, but, cause and effect can only be established if
one event precedes the other. In addition, such precedence only
provides evidence of plausibility and not causation (post hoc ergo
propter hoc). And while neither outcome is observed after
3 weeks of CAP exposure, an increase in plasma TNF-a is, indicat-
ing that systemic inﬂammation is a likely catalyst for not only
systemic glucose intolerance and hepatic NASH changes, but also
for vascular inﬂammation as well [8]. In fact, the liver is not a
major organ of glucose disposal and, with the depletion of hepatic
glycogen stores in CAP-exposed mice, it is not clear exactly how
the liver contributes to systemic glucose intolerance. Although
there are examples where high fat diet-induced changes in
liver-speciﬁc JAK2-null mice [9] or in type II natural killer T cells
(NKT II cells) [10] lead to insulin resistance, it is not clear whether
these or other mechanisms are operative in CAP-induced
changes. Finally, Zheng and colleagues did not assess hepatic
insulin signaling (directly) or hepatic gluconeogenesis via pyru-13 vol. 58 j 8–10
Table 1. Estimated PM2.5 that reaches the mouse liver in a 6-h CAP exposure.
Ventilation rate, 
bpm
Tidal volume, 
μl
Total air exchange 
(6h; L)
[CAP], 
µg/1000 L
PM2.5 inspired, 
μg
PM2.5 deposited, 
μg
Blood volume,
ml
Blood [PM2.5], 
μg/ml 
115 200 7.2 75 0.54 0.108 2 0.054
Conversions:1 m3 = 1000 L.
JOURNAL OF HEPATOLOGYvate tolerance test (PTT) [11]. The speciﬁc role of hepatic changes
in the progression of pre-diabetes and insulin resistance state is,
therefore, unclear, and thus, additional mechanistic studies are
required to distinguish causation from association.Is the liver a direct or indirect target of CAP?
While two critical events highlighted in this study, i.e., elevated
plasma TNF-a and progression to NASH, remain enigmatic, it is
likely that uncovering the mechanisms of these changes is a
key step to understanding the deleterious effects of CAP exposure
on hepatic health. For example, several studies have shown that
chronic exposure to real-world CAP leads to inﬂammation local-
ized in the lung that precedes systemic and vascular inﬂamma-
tion [8]. The study of Zheng et al. modiﬁes this view by
showing that plasma TNF-a levels are elevated in 3- and 10-week
CAP-exposed mice yet no speciﬁc organ appears to be concur-
rently inﬂamed at 3 weeks. Alternative to a single-organ source
of TNF-a, the activation of macrophages and lymph nodes and
perhaps low-level inﬂammation of multiple tissues such as vas-
cular endothelium and perivascular adipose [8] is sufﬁcient to
collectively increase plasma TNF-a. In any case, the role of sys-
temic inﬂammation remains a central tenet of CAP-induced
changes, although a speciﬁc mechanism for progressive hepatic
changes is not deﬁnitively shown in this study.
So, it is unknown whether the presence of PM2.5 in the liver is
causal in the progression from a normal liver state to a NASH-like
condition. Using transmission electron microscopy (TEM), Laing
and colleagues (2010) demonstrated the presence of PM2.5 in
the liver (and lung) of CAP-exposed mice but they did not assess
if the presence of PM2.5 in the liver directly caused liver (or lung)
endoplasmic reticulum stress (ER stress) [12]. Similarly, the pres-
ence of PM2.5 in the liver is not measured in the current Zheng
et al. study, and because they did not show PM2.5 in the liver, it
is unclear whether hepatic PM2.5 is necessary or sufﬁcient to trig-
ger hepatic inﬂammation. In the current study, for example, cul-
tured macrophages incubated with PM2.5 become inﬂamed and
their secretions activate hepatic stellate cells. If PM2.5 is present
in the liver after 3 weeks, then it would follow that the quantity
of PM2.5 is not enough to stimulate hepatic inﬂammation or any
other change for that matter. Moreover, if PM2.5 is present in
the liver, how does it get there? Lung clearance via pulmonary air-
way mucociliary transport and translocation of inhaled PM to
extra-pulmonary sites has been a topic of interest for half a cen-
tury [13]. It is also possible that mice ingest PM2.5 from their
fur. In both scenarios, PM2.5 could reach the liver but the hepatic
effects would not necessarily depend on changes in the lung or
elsewhere. Instead, hepatic effects would arise from the direct
contact of PM2.5 and resident phagocytic hepatic cells (e.g., Kupf-
fer cells), which are demonstrated in incubation experiments. If,
however, there is no hepatic presence of PM2.5, it would be
unclear whether experiments using an incubation of PM2.5
[5 lg/ml] with macrophages are relevant. If PM2.5 does reach
and accumulate in the liver and in quantities sufﬁcient enoughJournal of Hepatology 2to trigger hepatic inﬂammation, then additional experimentation
could establish a route-dependent effect (e.g., gavage PM2.5) that
is independent of inhalation. Perhaps the presence of PM2.5 in
the liver is neither sufﬁcient nor adequate and is only a conse-
quence of swallowed PM2.5 that has been cleared (i.e., ‘‘bystander
effect’’). Both possibilities have important implications for PM
exposure in humans as worldwide air pollution and the use of
nanoparticles in both creams and nanomedicine (e.g., imaging;
delivery of anti-cancer treatments) are on the rise. The pathways
of clearance shared by PM and nanoparticles [13] could poten-
tially signify particle-related hepatotoxicity in the future, but
the veracity of this argument relies onmeasurements made under
real-world exposures, and not those resulting from unrealistic
in vitro conditions. As such, I estimated how much PM2.5 could
realistically be ingested and translocated after a CAP exposure
(Table 1). Even if all of the ingested CAP (PM2.5) enters the blood
after intestinal uptake, approximately 0.054 lg/ml, it is still a
level nearly 2-orders of magnitude below the incubation level
used in the study of Zheng et al. This ‘thought experiment’ does
suggest that PM2.5 might accumulate in the liver over time even-
tually reaching levels that could alter hepatic signaling and func-
tion, as described in Laing et al. (2010) where a similar 10-week
CAP exposure in mice triggered endoplasmic reticulum stress
(ER stress) in liver and lung [12]. There is no doubt, however, that
the use of TEM is a difﬁcult technique for quantifying the presence
of hepatic or lung PM2.5. Thus, in order to promote interventions
that can abrogate or eliminate this risk, there is a need to deter-
mine the mechanisms by which PM2.5 exposure promotes the
development of NASH-like conditions in healthy animals.Financial support
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